Daniel L. Baker advances computational drug discovery and antimicrobial biomaterials, bridging chemistry, materials science, and pharmacology. He builds structure‑based and ML workflows for GPCR ligand screening and designs biofilm‑resistant wound dressings and implant coatings to prevent infection.